tech. enhancements -- half-life/stealthing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : tech. enhancements -- half-life/stealthing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (15)	10/18/2001 4:44:28 PM
From: keokalani'nui	Read Replies (1) of 53

I know you didn't suggest it, but your pointer to Dynavax and other remarks about Coley made me scramble to see if idb's proteosomes were in for some collateral damage in the interference proceedings. Though the claimed switch to Th1 from Th2 is the same song, it appears (and this is more for me than you) that idb's proteosomes do not depend on bacterial oligonucleotide DNA for their structure or stimulatory effect. Assuming, that is, idb is using purified (or even synthetic?) bacterial membranes. I won't know for sure however until I can see a copy of Vaccine, probably months from now. Anyway, thanks, I have learned some really interesting stuff about coley's and dynavax's IP. NRN. Wilder

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next